Lv31
210 积分 2023-04-17 加入
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
2天前
已完结
The antibody–drug conjugate landscape
2个月前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
3个月前
已完结
Split-enzyme immunoassay to monitor EGFR-HER2 heterodimerization on cell surfaces
11个月前
已完结
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
1年前
已完结
Spy chemistry enables stable protein immobilization on iron oxide nanoparticles with enhanced magnetic properties
1年前
已完结
ScFv Improvement Approaches
1年前
已完结
De novo design and Rosetta‐based assessment of high‐affinity antibody variable regions (Fv) against the SARS‐CoV ‐2 spike receptor binding domain ( RBD )
1年前
已完结
Computational enzyme redesign: large jumps in function
1年前
已完结
皖公网安备34019202002308
